Rosales, Mercedes H.
HRN: 26-90-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/03/2025
04/10/2025
IV
1.5g
Q6
Non Healing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes